EDA Egypt Medical Device Registration

Medical devices and in vitro diagnostics in Egypt are regulated by the Egyptian Drug Authority (EDA), including its Central Administration of Medical Devices. EDA publishes current circulars and submission guidance through its official medical device regulatory-guidelines page. Because the guidance library is updated frequently, applicants should identify the instrument in force for their product and filing date.

Egypt market-entry planning

The route depends on product qualification, risk, intended use, technology, and the evidence available from reference markets. Medical devices and IVDs should be analyzed separately where the applicable rules distinguish them. Borderline products, software, sterile devices, measuring devices, and products incorporating medicinal substances may require additional classification or evidence work.

A foreign manufacturer generally works through an eligible Egyptian applicant or representative that can interact with EDA and support importation and lifecycle obligations. The agreement should define dossier access, authority communications, validity and renewal work, change reporting, complaint handling, vigilance, recalls, and transfer arrangements.

Registration evidence

A typical dossier includes administrative forms, manufacturer and manufacturing-site information, authorization documents, quality-management-system evidence, intended use, classification rationale, device descriptions, reference-market approvals or free-sale documentation where applicable, labeling and instructions for use, risk management, verification and validation, and clinical or performance evidence proportionate to risk. Arabic labeling and local applicant information must remain consistent with the approved device.

The exact submission channel, legalization requirements, fees, samples, and review steps should be confirmed from the current EDA guideline. A CE certificate or other reference approval may be important supporting evidence, but it does not remove the need to meet Egypt-specific administrative, labeling, representation, and post-market requirements.

After approval

Before shipment, verify the issued registration scope, models, manufacturer, sites, validity, labels, and import documentation. Manufacturers and local partners need procedures for complaints, adverse-event evaluation, field safety corrective actions, recalls, and authority communication. Changes to design, intended use, software, labeling, manufacturing site, or the quality system should be assessed before implementation to determine whether EDA notification, amendment, or a new filing is required.

Egypt pathway and evidence decisions

EDA’s library includes distinct imported/local-device and quality-certificate routes, change guidance and 2026 UDI guidance. Select the actual instrument and effective conditions for the product. A device in dosage form or another specialized category must not automatically use a general equipment checklist.

Use the official EDA instructions and related official process guidance for the filing scope. Maintain a controlled record of the chosen route, current evidence, open gaps, responsible parties and authority responses. Separate fees, document preparation, review and applicant work when planning the launch.

For a multi-country program, use the market directory to coordinate evidence reuse while retaining the local applicant, language, registration and postmarket requirements for each destination.